Search results
...Cannabis Post-Rescheduling? Data Analytics Expert Weighs In - Corbus Pharmaceuticals...
Benzinga· 2 days agoRoy Bingham, CEO of BDSA, anticipates substantial growth in the U.S. cannabis market, projecting...
Nipocalimab's Unique Mechanism Gets Second Chance in RA
Medscape· 4 days agoThe IRIS-RA study of the investigational monoclonal antibody drug nipocalimab in patients with...
Experts Share Practical Tips for Diagnosing Mild HS
Medscape· 4 days agoBased on his experience caring for patients with hidradenitis suppurativa (HS), dermatologist Christopher Sayed, MD, said that an exhaustive battery of...
Collaboration Tackles Steroid-Induced Adrenal Insufficiency
Medscape· 18 hours agoEndocrinologists in Europe and the United States have come together to produce joint guidance to...
15 Best Dividend Stocks and How To Invest in Them Today
GoBankingRates via AOL· 3 days agoWith dividend stocks, investors can enjoy reliable income from dividends and potential future growth...
Ironwood (IRWD) Q1 Earnings & Revenues Fall Shy of Estimates
Zacks via Yahoo Finance· 6 days agoIronwood (IRWD) incurs loss in the first quarter of 2024. Revenues decline year over year and miss...
SHAED on Authenticity and Searching for a Sense of Purpose: Podcast
Consequence of Sound via Yahoo News· 2 days agoThe trio touch on the pros and cons of associating themselves so closely with their work. SHAED on...
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates LABP, DOMA, FXNC - First Ntl (NASDAQ:FXNC), Doma...
Benzinga· 5 days agoLandos Biopharma, Inc. LABP's sale to AbbVie Inc. Under the terms of the proposed transaction, AbbVie would acquire Landos for $20.42 per share in cash ...
NeuroSense taps PhaseV’s ML tech for Phase III ALS trial analysis
Clinical Trials Arena via Yahoo Finance· 2 days agoPhaseV will analyse NeuroSense’s Phase II ALS trial data, and results from these will inform Phase...
Pharma Stock Roundup: PFE DMD Study Patient Death, FDA Panel Meet for LLY's Donanemab
Zacks via Yahoo Finance· 6 days agoPfizer (PFE) reports the death of a participant in a mid-stage study of its Duchenne drug. An FDA...